Third Rock Ventures GP IV, L.P. (CIK 1688326) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-11-05). Recent activity: Sell MAZE (1.6M shares), Sell TNGX (477,401 shares), Sell TNGX (500,000 shares), Sell TNGX (363,541 shares), Sell TNGX (642,906 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-05 | Maze Therapeutics, Inc. (MAZE) | 10% Owner | Sell | 1.6M | $0 |
| 2025-10-27 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 477,401 | $4.8M |
| 2025-09-29 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 500,000 | $4.0M |
| 2025-09-17 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 363,541 | $2.6M |
| 2025-09-09 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 642,906 | $4.5M |
| 2025-09-09 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 86,459 | $608,671 |
| 2025-08-26 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 302,194 | $2.1M |
| 2025-08-21 | Tango Therapeutics, Inc. (TNGX) | 10% Owner | Sell | 1.1M | $7.7M |
来源：SEC Form 4 申报文件 · 截至 2025-11-05